Welcome to CanLiv
The Hepatobiliary Cancers Foundation:
Cancers of the bile ducts, gallbladder and liver, commonly referred to as hepatobiliary cancers, are "orphan" cancers that:
Click on the Symposium Invitation below
to access Symposium Goals, Agenda, and Registration
- Are rare in the United States, but affect many thousands of individuals worldwide. Liver cancer (hepatocellular, HCC) is the 4th most common cancer worldwide.
- Have few treatment options and have attracted little research funding or public attention.
- Do not have an organized group to advocate for increased research and improved treatment options.
Who We Are:
CanLiv was created by a group of
physicians,
scientists, and
dedicated individuals who are
committed to advancing
knowledge, education, research and treatment of hepatobiliary cancers.
What We Do:
CanLiv's mission is to improve the lives of individuals diagnosed with cancer of the bile ducts, gallbladder and liver, by providing accurate, current information, calling public attention to these orphan tumors, and supporting translational and clinical research to improve patients'outcome.
This website is designed to support and educate patients, families and caregivers, by providing background and treatment information on these cancers. This site is intended to help you, but not replace discussions or information provided to you by your medical professionals.
CanLiv is a tax-exempt, not for profit charitable foundation headquartered in New York.
